August 28, 2023 — On Friday, NEJM published impressive results in an RCT of semaglutide for treating patients who have obesity and heart failure with preserved ejection fraction (HFpEF). The treatment enabled these people to function better, feel better, and suffer half as many serious adverse events. These are important benefits for people with a very difficult condition. But […]
August 26, 2023 — Scientists who study semaglutide in obesity are producing a steady stream of impressive results. Yesterday in the New England Journal of Medicine, a randomized controlled trial in persons with obesity and heart failure with preserved ejection fraction demonstrated superior weight reduction, improvement in heart failure, better physical functioning, and a halving of serious adverse events. […]
February 10, 2021 — High intensity interval training (HIIT) is hot right now. It mixes short periods of very intense exercise with less intense recovery. Even before the pandemic, interest in HIIT had grown dramatically. Then it spiked when pandemic lockdowns began. But a new RCT published yesterday in JAMA suggests that it might not be a panacea for […]
October 24, 2019 — Applying the science of health outcomes research to social determinants of health is bringing surprising insights. In fact, for chronic diseases like obesity, heart failure, and diabetes, delivering better nutrition might do more than merely prescribing medicine can. Also, it seems to seems to offer good value for money. Food Is Medicine? This catchphrase sometimes […]
December 24, 2017 — It’s here. On this holiday, many people will stop everything as they gather with family for a festive time and seasonal foods. Maybe it’s a goose, maybe it’s eggnog. or maybe it’s Chinese food. Though a bit of mindfulness might help, the menu is probably out of your hands. So your best bet for seeking […]
November 10, 2015 — If you thought that the onslaught of new studies was done with the closing of ObesityWeek on Friday, think again. Now we have two important new studies of liraglutide and heart disease that were presented at the Annual Scientific Sessions of the American Heart Association (AHA) on Sunday and Monday. The study that’s hogging all the […]
